Trial Profile
Efficacy and tolerability of telaprevir (TVR)-based triple therapy in HIV/HCV-coinfected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 14 Oct 2015 New trial record